Summary
- Current Price
- As of today, SLNO price is $31.86, up +0.06% on
- Current Price All-Time High
- SLNO price is currently -95.71% below its historical high of $742.50 set on
- Market Cap
- SLNO current market cap is $2B, down -23.80% year-over-year
- PE Ratio
- SLNO current PE ratio is 143.00
- Revenue
- SLNO current annual revenue is $190.41M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for SLNO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Soleno Therapeutics, Inc. |
| Ticker | NASDAQ: SLNO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | soleno.life |
| Employees | 115 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $31.86 | |
| Price, 1D Change | +0.06% | |
| $2B | ||
| - | ||
| 143.00 | ||
| 0.70 | ||
| $190M | ||
| Revenue, 1Y Change | +100.00% | |
| $0.39 | ||
| EPS, 1Y Change | +108.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CAPN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.39 | ||
| EPS Estimate | N/A | $3.89 |
| EPS Est. Change | N/A | +895.14% |
| $190.41M | ||
| Revenue Estimate | N/A | $469.99M |
| Revenue Est. Change | N/A | +146.84% |
| Current Price | $31.86 | |
| Price Target | - | $107.00 |
| Price Tgt. Change | - | +235.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.18 | -$4.38 | -4.61% | |
| $0.29 | $0.39 | +33.37% | |
| $3.89 | N/A | +895.14% | |
| $6.56 | N/A | +1,578.41% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $187.28M | $190.41M | +1.67% | |
| $469.99M | N/A | +146.84% | |
| $721.79M | N/A | +279.08% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $31.86 | |
| $58.44 | ||
| SMA 200 vs Price | +83.42% | |
| $38.86 | ||
| SMA 50 vs Price | +21.98% | |
| 0.70 | ||
| $2.04 | ||
| 31.97 | ||
| 49.18% | ||
| 73.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $190.41M | ||
| $0.39 | ||
| $187.71M | ||
| 98.58% | ||
| $14.95M | ||
| 7.85% | ||
| $20.48M | ||
| 10.75% | ||
| $16.97M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 5.80 | ||
| 5.55 | ||
| - | ||
| - | ||
| 9.01 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 143.00 | ||
| 8.99 | ||
| 3.80 | ||
| 85.95 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $450.11M | ||
| $305.47M | ||
| $563.83M | ||
| $355.81M | ||
| $113.72M | ||
| $61.36M | ||
| $52.55M | ||
| $726.00K | ||
| $12.44M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $169.93M | ||
| $172.76M | ||
| $2.70M | ||
| $0.00 | ||
| $2.02M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $46.74M | ||
| -$201.78M | ||
| $137.22M | ||
| $73.00K | ||
| $46.66M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| TD Cowen | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wolfe Research | ||
| Wells Fargo | → | |
| Guggenheim | → | |
| Wells Fargo |
Analyst sentiment
Institutional ownership
Screeners with SLNO
FAQ
What is the ticker symbol for Soleno Therapeutics, Inc.?
The ticker symbol for Soleno Therapeutics, Inc. is NASDAQ:SLNO
Does Soleno Therapeutics, Inc. pay dividends?
No, Soleno Therapeutics, Inc. does not pay dividends
What sector is Soleno Therapeutics, Inc. in?
Soleno Therapeutics, Inc. is in the Healthcare sector
What industry is Soleno Therapeutics, Inc. in?
Soleno Therapeutics, Inc. is in the Biotechnology industry
What country is Soleno Therapeutics, Inc. based in?
Soleno Therapeutics, Inc. is headquartered in United States
When did Soleno Therapeutics, Inc. go public?
Soleno Therapeutics, Inc. initial public offering (IPO) was on November 13, 2014
Is Soleno Therapeutics, Inc. in the S&P 500?
No, Soleno Therapeutics, Inc. is not included in the S&P 500 index
Is Soleno Therapeutics, Inc. in the NASDAQ 100?
No, Soleno Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Soleno Therapeutics, Inc. in the Dow Jones?
No, Soleno Therapeutics, Inc. is not included in the Dow Jones index
When was Soleno Therapeutics, Inc. last earnings report?
Soleno Therapeutics, Inc.'s most recent earnings report was on February 25, 2026
When does Soleno Therapeutics, Inc. report earnings?
The next expected earnings date for Soleno Therapeutics, Inc. is May 6, 2026
Data Sources & References
- SLNO Official Website soleno.life
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1484565/000119312526071808/0001193125-26-071808-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1484565/000119312526071808/0001193125-26-071808-index.htm
- SLNO Profile on Yahoo Finance finance.yahoo.com/quote/SLNO
- SLNO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/slno